VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Sunday, January 11, 2026
Stock Comparison
Morningstar, Inc. vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Morningstar, Inc.
MORN · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Morningstar, Inc.'s moat claims, evidence, and risks.
View MORN analysisRoche Holding AG
ROG · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROG analysisComparison highlights
- Moat score gap: Roche Holding AG leads (68 / 100 vs 67 / 100 for Morningstar, Inc.).
- Segment focus: Morningstar, Inc. has 7 segments (34.6% in Morningstar Data and Analytics); Roche Holding AG has 2 segments (76.3% in Pharmaceuticals).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Morningstar, Inc. has 6 moat types across 3 domains; Roche Holding AG has 5 across 3.
Primary market context
Morningstar, Inc.
Morningstar Data and Analytics
Investment data, research, and analytics platforms
Global
34.6%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
76.3%
Side-by-side metrics
Moat coverage
Shared moat types
Morningstar, Inc. strengths
Roche Holding AG strengths
Segment mix
Morningstar, Inc. segments
Full profile >Morningstar Data and Analytics
Oligopoly
PitchBook
Oligopoly
Morningstar Credit
Oligopoly
Morningstar Wealth
Competitive
Morningstar Retirement
Competitive
Morningstar Sustainalytics
Oligopoly
Morningstar Indexes
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.